Clinical Outcome Comparison Between Medial and Lateral Offset Reverse Shoulder Arthroplasty
NCT ID: NCT01086202
Last Updated: 2016-09-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
37 participants
OBSERVATIONAL
2010-05-31
2014-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Onlay Versus Inlay Humeral Component in Reverse Total Shoulder Arthroplasty
NCT05297305
Influenze of Approach in Reversed Shoulder Prosthesis
NCT04405947
Reverse Shoulder Arthroplasty vs Rotator Cuff Repair for 60+
NCT06848023
Clinical Trial to Analyze Lateralized Models and Medializations of Inverted Arthroplasty.
NCT05847062
Reverse Total Shoulder Arthroplasty: A Data Analysis on Patients Undergoing Reverse Total Shoulder Arthroplasty
NCT03617107
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patients meeting criteria must be between the ages of 50 and 95 years of age and are a candidate for a reverse shoulder arthroplasty. This is includes patients with rotator cuff tear arthroplasty, irreparable rotator cuff tears, significant proximal humerus fractures and malunions, and chronic proximal humerus dislocators. A total of 40 patients will be enrolled and randomized to either one of two groups; 20 patients will be randomized to the Tornier Reversed shoulder Arthroplasty Medial offset, and 20 will receive the Lateral offset design. Both implants are FDA approved. The patients will be followed for 24 months and will follow-up will be at 6 weeks, 3 months, 6 months, 12 months and 24 months questionnaires will be completed at each visit, x-rays will be done at pre-op, 3 month, 6 months 12 and 24 months.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Tornier Reversed Shoulder Arthroplasty Medial Offset
No interventions assigned to this group
Lateral offset arthroplasty
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* rotator cuff tear arthroplasty,
* irreparable rotator cuff tear,
* significant proximal humerus fracture and malunions,
* chronic proximal humerus dislocation.
Exclusion Criteria
2. Patient who will need additional procedures including: bone grafting of the glenoid and muscle transfer.
3. Patients who do not want to participate or participate in follow-ups.
50 Years
90 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Loma Linda University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Wesley P. Phipatanakul
M.D. Asscoaite Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Wesley Phipatanakul, MD
Role: PRINCIPAL_INVESTIGATOR
Loma Linda University Health Dept. Orthopaedic Surgery
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Loma Linda University Health Care Dept. of Orthopaedic Surgery
Loma Linda, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
59247
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.